Insiders / Friedman Paul a

Friedman Paul a

CIK 1236927personinsider

Companies

2

First seen

Jan 13, 2026

Last activity

Jun 10, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Madrigal Pharmaceuticals, Inc. · MDGL	Director	187,164	211,684	33	—
Prelude Therapeutics Incorporated · PRLD	Director	—	38,000	1	—

All securities held

3 positions · latest reported per filing

Company	Security	Shares	As of
Madrigal Pharmaceuticals, Inc.	Common Stock	187,164	Jan 9, 2026
Madrigal Pharmaceuticals, Inc.	Stock Option (Right to Buy)Derivative	280	Jan 9, 2026
Prelude Therapeutics Incorporated	Director Stock Option (Right to Buy)Derivative	38,000	Jun 9, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$1.28M	-2K -1.24%	194,222 0.84% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$1.27M	-2K -1.20%	202,553 0.88% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$1.03M	-2K -0.96%	205,769 0.89% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$822.1K	-2K -0.81%	191,596 0.83% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$757.7K	-1K -0.70%	210,204 0.91% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$707.0K	-1K -0.67%	201,190 0.87% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$692.2K	-1K -0.64%	207,765 0.90% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$628.4K	-1K -0.61%	196,654 0.85% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$561.3K	-1K -0.52%	209,110 0.91% of shares	medium
Jan 9, 2026	Sell	MDGL Madrigal Pharmaceuticals, Inc. Common Stock	$560.7K	-1K -0.55%	193,156 0.84% of shares	medium